This is a Validated Antibody Database (VAD) review about rat Ercc1, based on 16 published articles (read how Labome selects the articles), using Ercc1 antibody in all methods. It is aimed to help Labome visitors find the most suited Ercc1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Santa Cruz Biotechnology
mouse monoclonal (D-10)
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology Ercc1 antibody (Santa Cruz, sc-17809) was used in western blot on human samples (fig 1a). Nucleic Acids Res (2018) ncbi
mouse monoclonal (D-10)
  • western blot; human; 1:1000; fig 3ai
Santa Cruz Biotechnology Ercc1 antibody (SantaCruz, sc17809) was used in western blot on human samples at 1:1000 (fig 3ai). Genome Biol (2018) ncbi
mouse monoclonal (D-10)
  • other; human; loading ...; fig 4c
Santa Cruz Biotechnology Ercc1 antibody (SantaCruz, sc-17809) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (8F1)
  • western blot; human; loading ...; fig 5c
Santa Cruz Biotechnology Ercc1 antibody (Santa Cruz, sc-56673) was used in western blot on human samples (fig 5c). PLoS ONE (2017) ncbi
mouse monoclonal (D-10)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Santa Cruz Biotechnology Ercc1 antibody (Santa Cruz, sc-17809) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
mouse monoclonal (SPM243)
  • immunohistochemistry; rat; loading ...; fig 101
In order to outline the protocols for antibodies used for immunohistochemical studies, Santa Cruz Biotechnology Ercc1 antibody (Santa Cruz, sc-56386) was used in immunohistochemistry on rat samples (fig 101). J Toxicol Pathol (2017) ncbi
mouse monoclonal (D-10)
  • reverse phase protein lysate microarray; human; loading ...; fig 3a
In order to describe the features of 228 primary cervical cancers, Santa Cruz Biotechnology Ercc1 antibody (SantaCruz, sc-17809) was used in reverse phase protein lysate microarray on human samples (fig 3a). Nature (2017) ncbi
mouse monoclonal (D-10)
  • immunocytochemistry; mouse; 1:200; fig 4
In order to elucidate ubiquitylation of XPC, Santa Cruz Biotechnology Ercc1 antibody (Santa Cruz, D10) was used in immunocytochemistry on mouse samples at 1:200 (fig 4). Nat Commun (2015) ncbi
mouse monoclonal (D-10)
  • immunocytochemistry; human; 1:150
In order to evaluate diagnostic markers for lung cancer with bronchial brushing specimens, Santa Cruz Biotechnology Ercc1 antibody (Santa Cruz Biotechnology, sc-17809) was used in immunocytochemistry on human samples at 1:150. Cancer Cytopathol (2014) ncbi
mouse monoclonal (3H11)
  • western blot; human
Santa Cruz Biotechnology Ercc1 antibody (Santa Cruz, sc-53281) was used in western blot on human samples . Anat Rec (Hoboken) (2014) ncbi
Abcam
mouse monoclonal (8F1)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1
Abcam Ercc1 antibody (Abcam, 8F1) was used in immunohistochemistry - paraffin section on human samples (fig s1). J Cancer Res Clin Oncol (2020) ncbi
mouse monoclonal (8F1)
  • immunohistochemistry; human; 1:100; loading ...; fig s8c
Abcam Ercc1 antibody (Abcam, ab2356) was used in immunohistochemistry on human samples at 1:100 (fig s8c). Nat Commun (2018) ncbi
mouse monoclonal (8F1)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 2
In order to evaluate biomarker profiling in recurrent epithelial ovarian cancer, Abcam Ercc1 antibody (Abcam, 8F1) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Oncotarget (2016) ncbi
mouse monoclonal (8F1)
  • immunohistochemistry - paraffin section; human
In order to use molecular profiling to assess expression of biomarkers of operable gastric adenocarcinoma being treated with epirubicin, cisplatin, and 5-fluorouracil, Abcam Ercc1 antibody (Abcam, 8F1) was used in immunohistochemistry - paraffin section on human samples . J Surg Oncol (2014) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1e, 1f
Cell Signaling Technology Ercc1 antibody (Cell Signaling, 3885s) was used in western blot on human samples (fig 1e, 1f). J Gynecol Oncol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s8b
Cell Signaling Technology Ercc1 antibody (Cell Signaling, 3885) was used in western blot on human samples at 1:1000 (fig s8b). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; mouse; fig s1.b,c
Cell Signaling Technology Ercc1 antibody (Cell Signaling Technology, 3885) was used in reverse phase protein lysate microarray on mouse samples (fig s1.b,c). EMBO Mol Med (2016) ncbi
Articles Reviewed
  1. Xiao L, Shi X, Li Z, Li M, Zhang M, Yan S, et al. Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway. J Gynecol Oncol. 2021;32:e77 pubmed publisher
  2. Heinzelmann Schwarz V, Kind A, Vetter M, Russell K, Omar S, Schoetzau A, et al. Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?. J Cancer Res Clin Oncol. 2020;146:695-704 pubmed publisher
  3. Sabatella M, Theil A, Ribeiro Silva C, Slyskova J, Thijssen K, Voskamp C, et al. Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features. Nucleic Acids Res. 2018;46:9563-9577 pubmed publisher
  4. Galanos P, Pappas G, Polyzos A, Kotsinas A, Svolaki I, Giakoumakis N, et al. Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability. Genome Biol. 2018;19:37 pubmed publisher
  5. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  6. Zhu B, Chen S, Wang H, Yin C, Han C, Peng C, et al. The protective role of DOT1L in UV-induced melanomagenesis. Nat Commun. 2018;9:259 pubmed publisher
  7. Ganapathy V, Manyanga J, Brame L, McGuire D, Sadhasivam B, Floyd E, et al. Electronic cigarette aerosols suppress cellular antioxidant defenses and induce significant oxidative DNA damage. PLoS ONE. 2017;12:e0177780 pubmed publisher
  8. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  9. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  10. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed publisher
  11. Gruosso T, Mieulet V, Cardon M, Bourachot B, Kieffer Y, Devun F, et al. Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients. EMBO Mol Med. 2016;8:527-49 pubmed publisher
  12. Herzog T, Spetzler D, Xiao N, Burnett K, Maney T, Voss A, et al. Impact of molecular profiling on overall survival of patients with advanced ovarian cancer. Oncotarget. 2016;7:19840-9 pubmed publisher
  13. van Cuijk L, van Belle G, Turkyilmaz Y, Poulsen S, Janssens R, Theil A, et al. SUMO and ubiquitin-dependent XPC exchange drives nucleotide excision repair. Nat Commun. 2015;6:7499 pubmed publisher
  14. Liu Y, Jiang Y, Wang B, Hao J, Shang L, Zhang T, et al. A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens. Cancer Cytopathol. 2014;122:833-41 pubmed publisher
  15. Miura J, Johnston F, Thomas J, George B, Eastwood D, Tsai S, et al. Molecular profiling in gastric cancer: examining potential targets for chemotherapy. J Surg Oncol. 2014;110:302-6 pubmed publisher
  16. Liu X, Chen L, Feng B, Liu G. Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma. Anat Rec (Hoboken). 2014;297:215-21 pubmed publisher